FIELD: medicine.
SUBSTANCE: present invention concerns to immunostimulating phosphorothioate CpG-oligonucleotides which can be used for stimulation of the immune response.
EFFECT: obtaining of CpG-oligonucleotides.
49 cl, 76 fig, 19 tbl, 34 ex
Title | Year | Author | Number |
---|---|---|---|
SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2005 |
|
RU2393223C2 |
CPG-OLIGONUCLEOTIDE ANALOGUES, CONTAINING HYDROPHOBIC T-ANALOGUES WITH AMPLIFIED IMMUNOSTIMULATORY ACTIVITY | 2007 |
|
RU2477315C2 |
IMMUNOSTIMULATING NUCLEIC ACIDS | 2000 |
|
RU2245149C2 |
IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
IMMUNOSTIMULATING G,U-CONTAINING OLYGORIBONUCLEOTIDES | 2003 |
|
RU2302865C2 |
PNEUMOCOCCAL VACCINE AND USING IT | 2010 |
|
RU2536248C2 |
IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
PCSK9 VACCINE | 2010 |
|
RU2538162C2 |
CH3 IGE PEPTIDE VACCINE | 2009 |
|
RU2495049C2 |
COMPLEX CONTAINING AN OLIGONUCLEOTIDE, HAVING IMMUNOSTIMULATING ACTIVITY, AND ITS APPLICATION | 2014 |
|
RU2723943C2 |
Authors
Dates
2008-11-20—Published
2003-08-19—Filed